The subjects with NAFLD also had higher levels of systolic blood pressure, FPG, alanine aminotransferase (ALT), glutamine transferase (GGT), HbA1c and urinary concentrations of MECPP and MEOHP. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.